Results 151 to 160 of about 46,312 (227)

Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin

Journal of Thrombosis and Haemostasis, 2017
I. Gouin-Thibault, I. Gouin-Thibault, X. Delavenne, A. Blanchard, A. Blanchard, V. Siguret, V. Siguret, J. Salem, J. Salem, C. Narjoz, P. Gaussem, P. Gaussem, P. Beaune, P. Beaune, C. Funck-Brentano, C. Funck-Brentano, M. Azizi, P. Mismetti, M. Loriot, M. Loriot   +19 more
semanticscholar   +1 more source

Is there a role for anticoagulation with dabigatran in S. aureus bacteremia? Protocol for the adjunctive treatment domain of the <i>Staphylococcus aureus</i> Network Adaptive Platform (SNAP) randomised controlled trial. [PDF]

BMJ Open
McDonald EG, Cheng MP, Davis JS, Goodman AL, Lawler PR, Marsh J, Mertz D, Paul M, Rodriguez-Baño J, Siegal DM, Tong SY, Walls G, Lee TC, SNAP Global Trial Steering Committee.   +13 more
europepmc   +1 more source

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Circulation, 2014
S. Schulman, A. Kakkar, S. Goldhaber, S. Schellong, H. Eriksson, P. Mismetti, A. Christiansen, J. Friedman, F. Le Maulf, N. Peter, C. Kearon   +10 more
semanticscholar   +1 more source

NOACs effects in the secondary prevention of atrial fibrillation-related ischemic stroke/TIA: a systematic review and meta-analysis. [PDF]

J Neurol
Zhao J, Chen C, Lu L, Wang L, Chen F.
europepmc   +1 more source

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

Journal of the American College of Cardiology, 2014
P. Reilly, T. Lehr, S. Haertter, S. Connolly, S. Yusuf, J. Eikelboom, M. Ezekowitz, G. Nehmiz, Susan Wang, L. Wallentin   +9 more
semanticscholar   +1 more source

Dabigatran-based versus warfarin-based triple antithrombotic regimen with a 1-month intensification after coronary stenting in patients with nonvalvular atrial fibrillation (COACH-AF PCI). [PDF]

BMC Med
Liang M, Jin J, Zhao R, Li H, Chen S, Liu L, Xu P, Wang W, Cheng X, Chen X, Tao L, Zhang Q, Yang M, Zeng C, Li L, Zheng Y, Chen H, Guo J, Zhong Z, Bi Y, Cheng B, Zhou Y, Wang H, Zhang Y, Qiu M, Zhang Q, Zhang P, Zhang J, Wang Z, Li Y, Han Y.   +30 more
europepmc   +1 more source

Dabigatran and Edoxaban in the Repair of an Abnormal Cleft in the Right Wall of the Ascending Aorta: A Case Report. [PDF]

Cureus
Takeuchi H.
europepmc   +1 more source

Direct Oral Anticoagulant Levels at Time of Elective Surgery. [PDF]

JAMA Netw Open
Camilleri E, Shahbabai P, Rad M, Huijzer CA, Huisman MV, van Dorp ELA, Visser LE, Guchelaar HJ, Cannegieter SC, van Rein N.   +9 more
europepmc   +1 more source

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

Circulation, 2011
J. Eikelboom, L. Wallentin, Stuart J. Connolly, M. Ezekowitz, Jeff S. Healey, Jonas Oldgren, Sean Yang, M. Alings, Scott Kaatz, S. Hohnloser, Hans-Christoph Diener, M. Franzosi, Kurt Huber, P. Reilly, Jeanne Varrone, Salim Yusuf   +15 more
semanticscholar   +1 more source

Simultaneous Bilateral Central Retinal Artery Occlusions: Partial Recovery With Multimodal Therapy. [PDF]

Cureus
Cai JR, Hawkins GC, Jia X, Newton A, Francis IC.   +4 more
europepmc   +1 more source